A judge on Friday extended a temporary block of the Trump Administration’s drastic cuts in medical research funding.

Privately-held Austria firm pharmaand GmbH (pharma&) today announced that the National Institute of Health and Care Excellence (NICE) has issued a positive recommendation for its Rubraca (rucaparib).

A new survey from Pew Research Center has found that most Americans think inflation, health care cost, and the federal budget ...

The epilepsy treatment is now approved as an add-on therapy for patients aged ≥ 2 years, following an appeal against NICE’s initial rejection.

A federal judge in Massachusetts temporarily blocked the cuts from taking effect earlier this month in response to separate ...

A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Hundreds of people in England with aggressive blood cancer are set to benefit from an innovative new treatment that reprogrammes a patient’s own immune cells to fight the disease after it was ...

Trials are taking place to see if “comedy-on-prescription” can help improve people’s mental health, reduce NHS costs and offer alternatives to antidepressants. Craic Health has secured grant funding ...

Hundreds of children in England with a rare and severe form of epilepsy are set to benefit from a new drug being rolled out on the NHS. Fenfluramine has been recommended by the National Institute for ...

Part two of this series sees Ravijyot Saggu explore pharmacological management recommendations from the new joint chronic ...

But two-year funding for a new type of surgery in Wales - which until that point was only available elsewhere in the UK - ...